The introduction of nicotinamide as a nicotine substitution in e-cigarette and smokeless goods signifies a big regulatory problem for the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is understood to work as a sedative at superior dosages6. The statements produced by Nico